Strata Skin Sciences (SSKN)
(Delayed Data from NSDQ)
$3.02 USD
0.00 (0.00%)
Updated Jul 12, 2024 11:50 AM ET
4-Sell of 5 4
C Value D Growth D Momentum D VGM
Price, Consensus and EPS Surprise
SSKN 3.02 0.00(0.00%)
Will SSKN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SSKN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SSKN
New Strong Buy Stocks for February 14th
Strata Skin Sciences, Inc. (SSKN) Reports Q3 Loss, Tops Revenue Estimates
SSKN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Tabula Rasa Healthcare (TRHC) Reports Q3 Loss, Tops Revenue Estimates
Strata Skin Sciences, Inc. (SSKN) Reports Q2 Loss, Tops Revenue Estimates
Health Catalyst (HCAT) Reports Q2 Loss, Tops Revenue Estimates
Other News for SSKN
STRATA Skin Sciences Pre-Announces Second Quarter 2024 Financial Results
STRATA Skin Sciences Sponsors Webinars Featuring Leading Dermatologists Discussing Benefits of XTRAC® and TheraClear®X Devices
Strata Skin Sciences sponsors webinars on XTRAC, TheraClearX devices
SSKN Stock Earnings: Strata Skin Sciences Misses EPS, Misses Revenue for Q2 2023
STRATA Skin Sciences’ TheraClear®X Acne Therapy System Found to be Safe and Effective for Acne Lesions Across All Fitzpatrick Skin Types with Favorable Tolerability and Patient Satisfaction as Published in Peer Reviewed Journal